Perspective Therapeutics Inc

ASE:CATX 4:00:00 PM EDT

3.44

-0.32 (-8.51%)

: $3.44 0.00 (0.00%)

Market Cap (Intraday)	233.62M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.19 Million
Adjusted EPS	-$0.29

See more estimates

10-Day MA	$3.56
50-Day MA	$2.84
200-Day MA	$5.32

See more pivots

Perspective Therapeutics Inc Stock, ASE:CATX

2401 Elliott Avenue, Suite 320, Seattle, Washington 98121

United States of America

Phone: +1.206.676.0900

Number of Employees: 119

http://perspectivetherapeutics.com

Description

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.